This paper proposes a new approach to identifying and estimating the time-varying average treatment effect (ATE) using panel data to control for unobserved xed effects. The proposed approach allows for treatment effect heterogeneity induced by unobserved xed effects. Under such heterogeneity, while existing panel data approaches identify and estimate the ATEs only for limited subpopulations, the proposed approach identi es and estimates the ATE for the entire population. The proposed approach requires two conditions: (i) The proportion of additive unobserved xed effects terms in the treated and untreated potential outcome models is constant across units and time, and (ii) We have exogenous variables that correlate with unobserved xed effect...
Identifying average treatment effects (ATE) from quasi-experimental panel data has become one of the...
This paper introduces average treatment effects conditional on the outcome variable in an endogenous...
BackgroundRandomized controlled trials are often used to inform policy and practice for broad popula...
This paper proposes a new approach to estimate the time-varying average treatment effect using panel...
We propose and examine a panel data model for isolating the effect of a treatment, taken once at bas...
© 2016 American Statistical Association. We propose the sharp identifiable bounds of the potential o...
This paper considers identification of treatment effects when the outcome variables and covari-ates ...
We show that two commonly employed estimation procedures to deal with correlated unobserved heteroge...
We study treatment-effect estimation, with a panel where groups may experience multiple changes of t...
In observational studies it is common to use matching strategies to consistently estimate the averag...
The Average Treatment Effect (ATE) is a global measure of the effectiveness of an experimental treat...
We propose a semiparametric method to estimate the average treatment effect under the assumption of ...
Identifying average treatment effects (ATE) from quasi-experimental panel data has become one of the...
Abstract—Recently there has been a surge in econometric work focusing on estimating average treatmen...
BackgroundRandomized controlled trials are often used to inform policy and practice for broad popula...
Identifying average treatment effects (ATE) from quasi-experimental panel data has become one of the...
This paper introduces average treatment effects conditional on the outcome variable in an endogenous...
BackgroundRandomized controlled trials are often used to inform policy and practice for broad popula...
This paper proposes a new approach to estimate the time-varying average treatment effect using panel...
We propose and examine a panel data model for isolating the effect of a treatment, taken once at bas...
© 2016 American Statistical Association. We propose the sharp identifiable bounds of the potential o...
This paper considers identification of treatment effects when the outcome variables and covari-ates ...
We show that two commonly employed estimation procedures to deal with correlated unobserved heteroge...
We study treatment-effect estimation, with a panel where groups may experience multiple changes of t...
In observational studies it is common to use matching strategies to consistently estimate the averag...
The Average Treatment Effect (ATE) is a global measure of the effectiveness of an experimental treat...
We propose a semiparametric method to estimate the average treatment effect under the assumption of ...
Identifying average treatment effects (ATE) from quasi-experimental panel data has become one of the...
Abstract—Recently there has been a surge in econometric work focusing on estimating average treatmen...
BackgroundRandomized controlled trials are often used to inform policy and practice for broad popula...
Identifying average treatment effects (ATE) from quasi-experimental panel data has become one of the...
This paper introduces average treatment effects conditional on the outcome variable in an endogenous...
BackgroundRandomized controlled trials are often used to inform policy and practice for broad popula...